The pathogenic process of SARS-Cov-2 is related to the mechanism by which the virus enters the host cell through binding to angiotensin-2 converting enzyme (ACE-2).[7] Currently, it has been proposed that genetic polymorphisms among different populations may influence the progression of COVID-19 reassortment. The gene discussed is ACE2; the disease is COVID-19.